Amarin Corp Plc (AMRN)

[Whalatane]

Yes back in the Anchor days ...Lovaza was a big seller especially in Spain as Omacor ...and generously reimbursed at that time .
From Grok

Omacor saw significant global sales growth in the late 2000s. For instance, a 2008 report noted a 52% increase in global end-user sales for Omacor/Lovaza, reaching USD 778 million, with strong growth in major European markets, including Spain. Specifically, European sales grew by 34% to USD 289 million in 2008.

Vascepa ( AMR101 ) was seen by my Cardiologist , as something I could take to lower my TG;s ( in the low 200 mg/dl's ) that wouldn't have the risk of increasing my LDL cholesterol .
That was the big knock ...at the time ...on Lovaza .
It was also widely assumed that lowering high TG's would lower CV event risk .
The R-IT data showed us that TG lowering by itself .....was just a small part of the CV risk reduction benefit from taking Vascepa

Kiwi